Background: Thrombotic microangiopathy (TMA) with non-deficient ADAMTS-13 (a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13) outcome is unknown hence the survival analysis correlating with ADAMTS-13 activity is conducted in Malaysia.
Methods: This was a retrospective epidemiological study involving all cases of TMA from 2012-2016.
Results: We evaluated 243 patients with a median age of 34.